K031865 is an FDA 510(k) clearance for the VITEK 2 GRAM POSITIVE MOXIFLOXACIN FOR STREPOCOCCUS PNEUMONIAE. This device is classified as a System, Test, Automated, Antimicrobial Susceptibility, Short Incubation (Class II - Special Controls, product code LON).
Submitted by bioMerieux, Inc. (Hazelwood, US). The FDA issued a Cleared decision on August 13, 2003, 57 days after receiving the submission on June 17, 2003.
This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.1645.